Literature DB >> 25862200

Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.

Molly D Congdon1, Elizabeth S Childress1, Neeraj N Patwardhan1, James Gumkowski1, Emily A Morris1, Yugesh Kharel2, Kevin R Lynch2, Webster L Santos3.   

Abstract

Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK1 and 2). Intervention of the S1P signaling pathway has attracted significant attention because alteration of S1P levels is linked to several disease states including cancer, fibrosis, and sickle cell disease. While intense investigations have focused on developing SphK1 inhibitors, only a limited number of SphK2-selective agents have been reported. Herein, we report our investigations on the structure-activity relationship studies of the lipophilic tail region of SLR080811, a SphK2-selective inhibitor. Our studies demonstrate that the internal phenyl ring is a key structural feature that is essential in the SLR080811 scaffold. Further, we show the dependence of SphK2 activity and selectivity on alkyl tail length, suggesting a larger lipid binding pocket in SphK2 compared to SphK1.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  S1P; SphK1; SphK2; Sphingosine kinase; Sphingosine-1-phosphate

Mesh:

Substances:

Year:  2015        PMID: 25862200      PMCID: PMC4580500          DOI: 10.1016/j.bmcl.2015.03.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

Review 2.  Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.

Authors:  Gregory T Kunkel; Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  Nat Rev Drug Discov       Date:  2013-08-19       Impact factor: 84.694

3.  Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Authors:  Noriko Takuwa; Wa Du; Erika Kaneko; Yasuo Okamoto; Kazuaki Yoshioka; Yoh Takuwa
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

4.  Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.

Authors:  Mark E Schnute; Matthew D McReynolds; Tom Kasten; Matthew Yates; Gina Jerome; John W Rains; Troii Hall; Jill Chrencik; Michelle Kraus; Ciaran N Cronin; Matthew Saabye; Maureen K Highkin; Richard Broadus; Shinji Ogawa; Kristin Cukyne; Laura E Zawadzke; Vincent Peterkin; Kaliapan Iyanar; Jeffrey A Scholten; Jay Wendling; Hideji Fujiwara; Olga Nemirovskiy; Arthur J Wittwer; Marek M Nagiec
Journal:  Biochem J       Date:  2012-05-15       Impact factor: 3.857

5.  Crystal Structure of Sphingosine Kinase 1 with PF-543.

Authors:  Jing Wang; Stefan Knapp; Nigel J Pyne; Susan Pyne; Jonathan M Elkins
Journal:  ACS Med Chem Lett       Date:  2014-10-27       Impact factor: 4.345

6.  Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.

Authors:  Yugesh Kharel; Mithun Raje; Ming Gao; Amanda M Gellett; Jose L Tomsig; Kevin R Lynch; Webster L Santos
Journal:  Biochem J       Date:  2012-10-01       Impact factor: 3.857

7.  Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.

Authors:  Kevin J French; Yan Zhuang; Lynn W Maines; Peng Gao; Wenxue Wang; Vladimir Beljanski; John J Upson; Cecelia L Green; Staci N Keller; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2010-01-08       Impact factor: 4.030

Review 8.  Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.

Authors:  Daniel Plano; Shantu Amin; Arun K Sharma
Journal:  J Med Chem       Date:  2014-02-11       Impact factor: 7.446

9.  Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression.

Authors:  Yujin Zhang; Vladimir Berka; Anren Song; Kaiqi Sun; Wei Wang; Weiru Zhang; Chen Ning; Chonghua Li; Qibo Zhang; Mikhail Bogdanov; Danny C Alexander; Michael V Milburn; Mostafa H Ahmed; Han Lin; Modupe Idowu; Jun Zhang; Gregory J Kato; Osheiza Y Abdulmalik; Wenzheng Zhang; William Dowhan; Rodney E Kellems; Pumin Zhang; Jianping Jin; Martin Safo; Ah-Lim Tsai; Harinder S Juneja; Yang Xia
Journal:  J Clin Invest       Date:  2014-05-16       Impact factor: 14.808

10.  Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent.

Authors:  Kai Liu; Tai L Guo; Nitai C Hait; Jeremy Allegood; Hardik I Parikh; Wenfang Xu; Glen E Kellogg; Steven Grant; Sarah Spiegel; Shijun Zhang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more
  4 in total

1.  Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.

Authors:  Elizabeth S Childress; Yugesh Kharel; Anne M Brown; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2017-04-25       Impact factor: 7.446

2.  Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors.

Authors:  Molly D Congdon; Yugesh Kharel; Anne M Brown; Stephanie N Lewis; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  ACS Med Chem Lett       Date:  2016-02-02       Impact factor: 4.345

3.  Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.

Authors:  Molly Congdon; Russell G Fritzemeier; Yugesh Kharel; Anne M Brown; Vlad Serbulea; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  Eur J Med Chem       Date:  2020-12-29       Impact factor: 6.514

4.  Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.

Authors:  Christopher D Sibley; Emily A Morris; Yugesh Kharel; Anne M Brown; Tao Huang; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2020-01-28       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.